Evista (raloxifene) affects the cycle of bone formation and breakdown in the body, and reduces loss of bone tissue.
Evista is used to treat or prevent osteoporosis in postmenopausal women. Evista is also used to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or who are otherwise at risk of invasive breast cancer.
Evista is not a cancer medication and will not treat breast cancer.
